Physician

Michael Adel Daniel Rofael, M.D.

According to 2025 Medicare claims, Michael Rofael, M.D. (NPI: 1992171805) practices interventional cardiology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PRISMA HEALTH MEDICAL GROUP-MIDLANDS (NPI: 1003307166; TIN: 471345819) and primary practice location at 29203-6863. Rofael is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Rofael's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 978 traditional Medicare patients, billed 2,128 HCPCS/CPT codes, and received $113,799 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,386 prescription claims across 178 beneficiaries totaling $1,213,923 in drug costs, led by Vyndamax (Tafamidis). Open Payments data shows 38 records totaling $1,029. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,432 and ending at $1,213,923. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$114K2023 Medicare payment: $17,357 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $113,799 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202379194$17,357
20249782,128$113,799

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$607K$1.2M2016 Drug cost: $5,432 (USD; Tot_Drug_Cst)2017 Drug cost: $14,436 (USD; Tot_Drug_Cst)2018 Drug cost: $2,773 (USD; Tot_Drug_Cst)2019 Drug cost: $50,716 (USD; Tot_Drug_Cst)2020 Drug cost: $33,428 (USD; Tot_Drug_Cst)2021 Drug cost: $42,761 (USD; Tot_Drug_Cst)2022 Drug cost: $12,278 (USD; Tot_Drug_Cst)2023 Drug cost: $35,209 (USD; Tot_Drug_Cst)2024 Drug cost: $1,213,923 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162079$5,432
201734209$14,436
201832140$2,773
201955389$50,716
202064266$33,428
202154277$42,761
202226105$12,278
202358163$35,209
20241781,386$1,213,923

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes8184$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more77132$82
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function183187$62
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes102247$58
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only612753$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis381,140$804,646
EntrestoSacubitril/Valsartan1346,421$144,101
JardianceEmpagliflozin773,748$72,804
FarxigaDapagliflozin Propanediol502,750$51,672
EliquisApixaban552,490$46,896

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,029Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Adel Daniel Rofael, M.D.?

Tedicare shows public-source Medicare data for Michael Adel Daniel Rofael, M.D. (NPI 1992171805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Adel Daniel Rofael, M.D. have ACO affiliation data?

Michael Adel Daniel Rofael, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Michael Adel Daniel Rofael, M.D.?

Michael Adel Daniel Rofael, M.D. is linked to PRISMA HEALTH MEDICAL GROUP-MIDLANDS (billing NPI 1003307166) in the available physician profile data.

Does Michael Adel Daniel Rofael, M.D. have Open Payments data?

Michael Adel Daniel Rofael, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.